New Marketplace
New Risk, New Business Models

New Health Care Risks Present Opportunities

Article · October 24, 2016

For decades, health care was among the least risky business sectors. Providers were ensured a margin under cost-plus reimbursement. Insurers avoided risk by engaging in massive amounts of underwriting and passing through expected costs, or passing on business altogether if margins were questionable. And drug and device manufacturers found patients and their physicians eager to embrace the latest innovations, as neither faced direct pressure to compare incremental costs with incremental benefits. For years, the drug and device sectors consistently generated some of the highest returns on the stock exchange.

Health care today is a much riskier proposition for all of these parties. Providers are facing bundled payments and shared savings schemes with downside risk. Insurers must take all comers and are losing billions as they try to guess at the health and utilization patterns of enrollees in the public health insurance marketplaces. Investment in devices has ground to a halt, and pharmaceutical companies — which already face tougher negotiations with insurers and PBMs — must now brace for the possibility of heavier regulatory oversight on price-setting, or even government-negotiated prices.

Yet where there is risk, there is opportunity.

The opportunity for new entrants is most apparent. For example, whole industries have arisen to support providers in the transition to fee-for-value. These span the gamut from consultancies focusing on ACO formation to information technology vendors developing products to enable these new ventures. The willingness of state Medicaid programs to shift risk to private-sector plans — specifically for patients with special needs — has also sparked new investment and innovation around caring for these vulnerable populations.

New risks rock boats for existing players, of course, potentially causing dramatic shifts in market position. Academic medical centers, formerly at the helm of the medical care kingdom, now face enormous strategic challenges as customers flee to lower-priced hospitals and outpatient rivals siphon off patients in lucrative service lines, such as diagnostic imaging and infusion therapy. On the drug/device side, manufacturers are struggling to redefine their role in a new world devoted to generating health rather than health care. These firms are trying to develop “end-to-end solutions” and partnerships with buyers, rather than adding bells and whistles and counting on buyers to pay for the shiniest new things.

While there is no one-size-fits-all strategy, there is a one-size-fits-all goal: put patients, who are the ultimate customers of health care, first. When organizations put customers first, they gain clarity on which opportunities to pursue and what operational trade-offs to make. As the critical decisions associated with health care spending shift from the negotiating table (insurers versus providers/vendors) to the kitchen table (customers versus providers/vendors), any health care organization seeking a sustainable market position must recognize that objective requires a singular focus on serving the customer best.

 

This post originally appeared in NEJM Catalyst on October 5, 2016.

New Call for Submissions ­to NEJM Catalyst

Connect

A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »

More From New Marketplace
ED Telehealth Express Care Service Patient Room

Revolutionizing the Delivery of Care for ED Patients

How the NYP OnDemand Emergency Department Telehealth Express Care Service reduced stay times and revisit rates in one year.

Targeting Unconscionable Prescription-Drug Prices — Maryland’s Anti–Price-Gouging Law

Why, in the early 21st century, are so many drugs that were cheaply available in the 20th century becoming prohibitively expensive?

The Economics of Indication-Based Drug Pricing

What would indication-based drug pricing accomplish?

Controlling the Cost of Medicaid

Both political parties should support policies that focus on incentives as a mechanism for improving and sustaining their value.

Resetting the Nation’s Health Care Quality Agenda

Poor measures of care quality have consequences. The National Quality Forum is essential to creating measures that are valid and reliable.

Opportunities for Private-Sector Entrepreneurship in Health Care Transformation

Two veterans of public service say that government can do only so much — which creates attractive business opportunities for entrepreneurs.

Moving Past the EHR Interoperability Blame Game

Why can't EHRs talk to one another? We never created the right incentives, but we pretend that we did.

Emerging from EHR Purgatory — Moving from Process to Outcomes

What's the effect of the mode of physician payment when it comes to EHRs?

Reframing Analytics: Transforming Insights into Action

Centralizing clinical data for an integrated delivery system revealed a surprising lesson: sometimes predictive analytics are not enough.

Infographic: The Effects of Health Insurance on Health and Survival

There is strong evidence that expansions in health coverage have increased people’s use of health care across multiple domains of well-being and reduced deaths overall.

Connect

A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »

Topics

Reframing the Conversation on Drug Pricing

We can’t afford for current trends to continue. There is only one solution.

Value Based Care

127 Articles

Jumping into Value-Based Reimbursement with Two…

What payers would like to see when it comes to engagement in value-based reimbursement and…

Jumping into Value-Based Reimbursement with Two…

What payers would like to see when it comes to engagement in value-based reimbursement and…

Insights Council

Have a voice. Join other health care leaders effecting change, shaping tomorrow.

Apply Now